Who Owns H.I.V.-Prevention Drugs? The Taxpayers, U.S. Says

November 8, 2019

(New York Times) – After years of prodding by patient advocates, federal officials on Wednesday sued the drug maker Gilead Sciences, charging that it had infringed government patents on the idea of preventing H.I.V. with a daily pill. The suit, by the Department of Health and Human Services, came as a pleasant shock to many critics of the company, including Democratic members of Congress who had pressed the administration to act. It is very rare for the government to take on a drug maker over patents. 

Recommended Reading